AstraZeneca Changes Its COVID-19 Vaccine Name From CoviShield To Vaxzevria Due To Blood Clots Controversy
AstraZeneca has rebranded and changed the name of its COVID-19 vaccine from CoviShield to Vaxzevria. The move is because the company is struggling to convince people that the vaccine is safe amidst the controversy that AstraZeneca COVID-19 vaccine is causing blood clots.